SHOULD DOPAMINE AGONIST TREATMENT FOR PROLACTINOMAS BE LIFELONG

被引:27
作者
FAGLIA, G
机构
[1] Institute of Endocrine Sciences, University of Milan, Milano, I-20122
关键词
D O I
10.1111/j.1365-2265.1991.tb00288.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:173 / 174
页数:2
相关论文
共 20 条
[1]   BROMOCRIPTINE TREATMENT REDUCES THE CELL-SIZE IN HUMAN MACROPROLACTINOMAS - A MORPHOMETRIC STUDY [J].
BASSETTI, M ;
SPADA, A ;
PEZZO, G ;
GIANNATTASIO, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (02) :268-273
[2]   GALACTORRHEA - SUCCESSFUL TREATMENT WITH REDUCTION OF PLASMA PROLACTIN LEVELS BY BROM-ERGOCRYPTINE [J].
BESSER, GM ;
MCNEILLY, AS ;
EDWARDS, CRW ;
PARKE, L ;
FORSYTH, IA .
BRITISH MEDICAL JOURNAL, 1972, 3 (5828) :669-&
[3]   SPONTANEOUS PREGNANCIES IN HYPERPROLACTINEMIC WOMEN [J].
CROSIGNANI, PG ;
SCARDUELLI, C ;
BRAMBILLA, G ;
CAVIONI, V ;
FERRARI, C .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1985, 19 (01) :17-20
[4]   CABERGOLINE - LONG-ACTING ORAL TREATMENT OF HYPERPROLACTINEMIC DISORDERS [J].
FERRARI, C ;
MATTEI, A ;
MELIS, GB ;
PARACCHI, A ;
MURATORI, M ;
FAGLIA, G ;
SGHEDONI, D ;
CROSIGNANI, PG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (06) :1201-1206
[5]   NECROTIC CHANGES IN PROLACTINOMAS AFTER LONG-TERM ADMINISTRATION OF BROMOCRIPTINE [J].
GEN, M ;
UOZUMI, T ;
OHTA, M ;
ITO, A ;
KAJIWARA, H ;
MORI, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (03) :463-470
[6]  
JOHNSTON DG, 1984, LANCET, V2, P187
[7]   EFFECTS OF A NEW PROLACTIN INHIBITOR, CV 205-502, IN THE TREATMENT OF HUMAN MACROPROLACTINOMAS [J].
KHALFALLAH, Y ;
CLAUSTRAT, B ;
GROCHOWICKI, M ;
FLOCARD, F ;
HORLAIT, S ;
SERUSCLAT, P ;
SASSOLAS, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) :354-359
[8]   LOW-DOSES OF DOPAMINE AGONISTS IN THE LONG-TERM TREATMENT OF MACROPROLACTINOMAS [J].
LIUZZI, A ;
DALLABONZANA, D ;
OPPIZZI, G ;
VERDE, GG ;
COZZI, R ;
CHIODINI, P ;
LUCCARELLI, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (11) :656-659
[9]   LONGITUDINAL EVALUATION OF PATIENTS WITH UNTREATED PROLACTIN-SECRETING PITUITARY-ADENOMAS [J].
MARCH, CM ;
KLETZKY, OA ;
DAVAJAN, V ;
TEAL, J ;
WEISS, M ;
APUZZO, MLJ ;
MARRS, RP ;
MISHELL, DR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 139 (07) :835-844
[10]   THE NATURAL-HISTORY OF IDIOPATHIC HYPERPROLACTINEMIA [J].
MARTIN, TL ;
KIM, M ;
MALARKEY, WB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (05) :855-858